Loading…

Newer Formulations of Risperidone: Remarks About Risperidone ISM

[...]as we already reported, the Risperidone ISM® product is reconstituted to an injectable suspension whose polymeric component precipitates in situ after an intramuscular injection, resulting in the formation of an implant, by solvent diffusion to body fluids. Risperidone is entrapped within that...

Full description

Saved in:
Bibliographic Details
Published in:CNS drugs 2020-10, Vol.34 (10), p.1087-1088
Main Authors: Anta, Lourdes, Mata, Elena, Ochoa Díaz de Monasterioguren, Lourdes
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]as we already reported, the Risperidone ISM® product is reconstituted to an injectable suspension whose polymeric component precipitates in situ after an intramuscular injection, resulting in the formation of an implant, by solvent diffusion to body fluids. Risperidone is entrapped within that implant polymeric matrix, which biodegrades slowly providing a sustained release of drug for up to 1 month [5]. [...]Risperidone ISM® is not an emulsion comprising two phases (internal and external) nor one that comprises microparticles or microspheres, as Clark and Taylor state in their article [1]. [6], what is stated is that the product results in the formation of implants, not in microparticles or microspheres as Clark and Taylor state. [...]Risperidone ISM® is not an emulsion, it does not present several phases, and it does not lead to in situ microparticles/microspheres after administration.
ISSN:1172-7047
1179-1934
DOI:10.1007/s40263-020-00762-0